Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis.
Zining LiuZhening ZhangHua LiuJunbing ChenPublished in: Future oncology (London, England) (2023)
Aim: The authors conducted a meta-analysis to determine the association between time-to-surgery (TTS) after neoadjuvant chemotherapy and patient outcomes in locally advanced gastric cancer. Methods: Electronic databases were searched to identify potential studies, in which the authors compared patient outcomes between those with TTS within 4 (and 6) weeks of completion of neoadjuvant chemotherapy and those after 4 (and 6) weeks. Results: Six studies, including 1238 patients, were eligible for inclusion. Pooled data showed no significant differences in rates of pathological complete response, major pathological response, ypN0, complications, R0 resection and operative time between groups of longer TTS and shorter TTS. Conclusion: There was no statistically advantageous impact of prolonged TTS on pathological and surgical outcomes. Large, population-based studies are warranted.
Keyphrases
- neoadjuvant chemotherapy
- locally advanced
- rectal cancer
- sentinel lymph node
- lymph node
- minimally invasive
- coronary artery bypass
- end stage renal disease
- squamous cell carcinoma
- case control
- radiation therapy
- phase ii study
- newly diagnosed
- ejection fraction
- chronic kidney disease
- big data
- prostate cancer
- risk factors
- surgical site infection
- machine learning
- clinical trial
- randomized controlled trial
- robot assisted
- skeletal muscle
- human health
- radical prostatectomy
- acute coronary syndrome
- metabolic syndrome
- early stage
- atrial fibrillation
- coronary artery disease
- glycemic control